Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide
- PMID: 11332993
- DOI: 10.1038/sj.cgt.7700290
Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide
Abstract
Feline kidney cells were transfected with a vector overexpressing cytochrome P450 2B1 (CYP2B1). Transfected cells acquired a new specific biochemical activity, which could be demonstrated by a rapid CYP2B1 detection assay and showed selective sensitivity to the antitumorigenic prodrug ifosfamide (IFO). Further, the cell-killing effect was also mediated on nonmodified cells like feline kidney cells, mouse lymphoma, and human pancreatic cells in the vicinity of the CYP2B1-expressing cells due to the diffusible nature of the activated IFO metabolites. One of these, phosphoramide mustard, causes interstrand DNA cross-linking and it has been thought that the inability to repair this damage results in apoptosis. Surprisingly, our results clearly demonstrate a necrotic mechanism of IFO-induced cell death. This may have important implications for the activation of the immune system during CYP2B1/IFO suicide gene therapy of cancer.
Similar articles
-
Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.Biochem Pharmacol. 2006 Sep 28;72(7):893-901. doi: 10.1016/j.bcp.2006.06.012. Epub 2006 Aug 2. Biochem Pharmacol. 2006. PMID: 16887103
-
Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450.Gene Ther. 1998 Aug;5(8):1070-8. doi: 10.1038/sj.gt.3300671. Gene Ther. 1998. PMID: 10326030
-
Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene.Cancer Res. 1996 Mar 15;56(6):1331-40. Cancer Res. 1996. PMID: 8640822
-
Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.Toxicol In Vitro. 2006 Mar;20(2):176-86. doi: 10.1016/j.tiv.2005.06.046. Epub 2005 Nov 15. Toxicol In Vitro. 2006. PMID: 16293390 Review.
-
Microencapsulated, CYP2B1-transfected cells activating ifosfamide at the site of the tumor: the magic bullets of the 21st century.Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S21-4. doi: 10.1007/s00280-002-0448-0. Epub 2002 Apr 12. Cancer Chemother Pharmacol. 2002. PMID: 12042985 Review.
Cited by
-
Encapsulated cells expressing a chemotherapeutic activating enzyme allow the targeting of subtoxic chemotherapy and are safe and efficacious: data from two clinical trials in pancreatic cancer.Pharmaceutics. 2014 Aug 11;6(3):447-66. doi: 10.3390/pharmaceutics6030447. Pharmaceutics. 2014. PMID: 25116885 Free PMC article. Review.
-
Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy).J Biomed Biotechnol. 2003;2003(1):48-70. doi: 10.1155/S1110724303209098. J Biomed Biotechnol. 2003. PMID: 12686722 Free PMC article.
-
Introduction to the background, principles, and state of the art in suicide gene therapy.Mol Biotechnol. 2005 May;30(1):71-88. doi: 10.1385/MB:30:1:071. Mol Biotechnol. 2005. PMID: 15805578 Review.
-
Long-Term Survival of Cellulose Sulphate-Encapsulated Cells and Metronomic Ifosfamide Control Tumour Growth in Pancreatic Cancer Models-A Prelude to Treating Solid Tumours Effectively in Pets and Humans.Life (Basel). 2023 Dec 18;13(12):2357. doi: 10.3390/life13122357. Life (Basel). 2023. PMID: 38137959 Free PMC article.
-
Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma.Cancer Biol Med. 2021 Jul 14;18(3):910-30. doi: 10.20892/j.issn.2095-3941.2020.0511. Cancer Biol Med. 2021. PMID: 34259424 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical